scPharmaceuticals Inc. provided earnings outlook for the year 2022. For the period, The company expects net loss to be $43 to $48 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | -1.69% | -1.21% | -35.09% |
14/05 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.09% | 147M | |
+51.82% | 797B | |
+39.94% | 628B | |
+16.95% | 323B | |
+9.49% | 300B | |
+17.19% | 244B | |
+0.29% | 223B | |
+10.00% | 214B | |
+5.30% | 163B | |
-6.29% | 153B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- Scpharmaceuticals Inc. Provides Earnings Outlook for the Year 2022